Gate Bioscience Funding: $135M Raised, Series B (2025)

Gate Bioscience funding overview

Gate Bioscience is a Biotech company based in Brisbane, CA. Gate Bioscience has raised $135M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2025. The round record for Gate Bioscience runs through 2025; nothing later has been disclosed. Investors on record include Forbion, Eli Lilly and Company, Versant Ventures, Andreessen Horowitz (a16z) Bio + Health, GV (Google Ventures), ARCH Venture Partners. 6 distinct backers are named across the disclosed rounds.

Gate Bioscience at a glance

Total raised: $135M
Latest round: Series B
Latest round date: November 2025
Industry: Biotech
Headquarters: Brisbane, CA
Notable investors: Forbion, Eli Lilly and Company, Versant Ventures, Andreessen Horowitz (a16z) Bio + Health, GV (Google Ventures), ARCH Venture Partners

Frequently asked about Gate Bioscience funding

How much has Gate Bioscience raised?: Gate Bioscience has raised $135M in total disclosed funding across the rounds on record.
Who has invested in Gate Bioscience?: Forbion, Eli Lilly and Company, Versant Ventures, Andreessen Horowitz (a16z) Bio + Health, GV (Google Ventures), ARCH Venture Partners are named among the investors backing Gate Bioscience.
What was the latest Gate Bioscience funding round?: The most recent disclosed round is a Series B, announced in November 2025.
Where is Gate Bioscience based?: Gate Bioscience is based in Brisbane, CA.
What sector does Gate Bioscience operate in?: Gate Bioscience is tracked under Biotech from Brisbane, CA, with $135M in disclosed funding.
When did Gate Bioscience last raise?: The last disclosed Gate Bioscience round closed in November 2025 at Series B.

We update the Gate Bioscience record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Brisbane and their backers are listed below.

Gate Bioscience Funding: $135M Raised, Series B (2025)

Gate Bioscience funding overview

Gate Bioscience at a glance

Frequently asked about Gate Bioscience funding

Gate Bioscience founders (1)

Companies related to Gate Bioscience (40)

Browse related funding lists (7)